Rick Hermsen
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancer.
Journal: BJU international
Published: April 20, 2026
Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 17, 2025
External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 26, 2025
[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine.
Journal: EJNMMI reports
Published: September 20, 2024
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy.
Journal: European urology oncology
Published: August 05, 2024
The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 19, 2024
True-Positive 18F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 21, 2023
The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 10, 2023
Quantitative and Qualitative Assessment of Urinary Activity of 18F-Flotufolastat-PET/CT in Patients with Prostate Cancer: a Post Hoc Analysis of the LIGHTHOUSE and SPOTLIGHT Studies.
Journal: Molecular imaging and biology
Published: August 10, 2023
Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 10, 2023
Reply to Francesco Montorsi, Simone Scuderi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80.
Journal: European urology
Published: January 16, 2023
Last Updated: 09/26/2026